What’s new in nonopioid drugs and adjuvant analgesics?
Important Notice
This site is intended for US Healthcare Professionals. By clicking continue, you are acknowledging that you are a US Healthcare Professional.
Russell K. Portenoy, MD, Chairman, Department of Pain Medicine & Palliative Care at Beth Israel Medical Center in New York, talks about the three, broad categories of pharmacotherapy in pain management – opioids, non-opioids, and non-traditional, or adjuvant, analgesics. The non-traditional class includes tricyclic antidepressants and serotonin/norepinephrine reuptake inhibitors, as well as newer drugs including gabapentinoids and NMDA receptor blockers.
This content was developed with Russell Portenoy, MD.
Russell Portenoy, MD has indicated the following financial disclosures during the past 12 months:
- Advisor/speaker
- Arsenal Medical Inc.
- Grupo Ferrer
- Xenon
Departmental educational/research grants
- Ameritox
- Archimedes Pharmaceuticals
- Boston Scientific
- Covidien Mallinckrodt Inc.
- Endo Pharmaceuticals
- Forest Labs
- K-Pax Pharmaceuticals
- Meda Pharmaceuticals
- Medtronics
- Otsuka Pharma
- ProStrakan
- Purdue Pharma
- Salix
- St. Jude Medical
